The renin-angiotensin system in blacks: Active, passive, or what?

[1]  N. Hollenberg,et al.  Renal Perfusion in Blacks: Alterations Caused by Insuppressibility of Intrarenal Renin With Salt , 2002, Hypertension.

[2]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy , 2002 .

[3]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[4]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.

[5]  Keith C. Norris,et al.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.

[6]  N. Hollenberg,et al.  Renal perfusion and function in healthy African Americans. , 2001, Kidney international.

[7]  G. Sagnella.  Why is plasma renin activity lower in populations of African origin? , 2001, Journal of Human Hypertension.

[8]  K. Jamerson.  Rationale for angiotensin II receptor blockers in patients with low-renin hypertension. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  N. Hollenberg,et al.  The paradox of the low-renin state in diabetic nephropathy. , 1999, Journal of the American Society of Nephrology : JASN.

[10]  Ind.,et al.  Levels of mineralocorticoids in whites and blacks. , 1999, Hypertension.

[11]  P. Whelton,et al.  The renin-angiotensin system and blood pressure: differences between blacks and whites. , 1999, American journal of hypertension.

[12]  R. Gillum,et al.  Coronary Heart Disease Incidence and Survival in African-American Women and Men: The NHANES I Epidemiologic Follow-up Study , 1997, Annals of Internal Medicine.

[13]  C. Rotimi,et al.  Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. , 1997, Circulation.

[14]  C. Rotimi,et al.  Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica , 1996, Journal of hypertension.

[15]  C. Rotimi,et al.  Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. , 1996, Hypertension.

[16]  L. Agodoa,et al.  End-stage renal disease in the USA: data from the United States Renal Data System. , 1996, American journal of nephrology.

[17]  R. Blantz,et al.  Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats: effect of sodium and salt restriction. , 1995, Journal of the American Society of Nephrology : JASN.

[18]  A. Manatunga,et al.  The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. , 1995, The Journal of clinical investigation.

[19]  T. Hostetter,et al.  The paradox of the renin-angiotensin system in chronic renal disease. , 1994, Kidney international.

[20]  M. Brier,et al.  Sodium kinetics in white and black normotensive subjects: possible relevance to salt-sensitive hypertension. , 1994, The American journal of the medical sciences.

[21]  N. Hollenberg,et al.  Regulation of aldosterone secretion in hypertensive blacks. , 1994, Hypertension.

[22]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[23]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[24]  J. Ingelfinger,et al.  Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. , 1993, The American journal of physiology.

[25]  B. McAllister,et al.  Bradykinin inhibition of EGF- and PDGF-induced DNA synthesis in human fibroblasts. , 1993, The American journal of physiology.

[26]  J. Fray,et al.  Pathophysiology of low renin syndromes: sites of renal renin secretory impairment and prorenin overexpression. , 1993, Kidney international.

[27]  D J Reda,et al.  Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .

[28]  M. Brier,et al.  Sodium kinetics in salt‐sensitive and salt‐resistant normotensive and hypertensive subjects , 1992, Journal of hypertension.

[29]  H. Langford,et al.  Chronic Effect of KCl on Black – White Differences in Plasma Renin Activity, Differences in Plasma Renin Activity , 1991 .

[30]  S. Rosansky,et al.  The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. , 1990, Archives of internal medicine.

[31]  P. Brazy,et al.  Progressive renal disease: role of race and antihypertensive medications. , 1990, Kidney international.

[32]  S. Björck.  The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study. , 1990, Scandinavian journal of urology and nephrology. Supplementum.

[33]  T. Pickering,et al.  Hypertension in blacks: psychosocial and biological perspectives. , 1989, Journal of hypertension.

[34]  P. Eggena,et al.  Renin regulation in type II diabetes mellitus: influence of dietary sodium. , 1989, Hypertension.

[35]  F. Beck,et al.  Salt Sensitivity in Blacks Salt Intake and Natriuretic Substances , 1988, Hypertension.

[36]  J. Angell-James,et al.  Modification of the Carotid Sinus Baroreceptor Reflex Control of the Circulation by Nifedipine , 1986 .

[37]  J. Laragh,et al.  Renin relationship to sex, race and age in a normotensive population. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[38]  J. Hall,et al.  The renin-angiotensin system and long-term regulation of arterial pressure. , 1986, Journal of hypertension.

[39]  S. Schuman,et al.  Childhood familial and racial differences in physiologic and biochemical factors related to hypertension. , 1983, Hypertension.

[40]  F. Luft,et al.  Sodium sensitivity and resistance in normotensive humans. , 1982, The American journal of medicine.

[41]  C. Gomez-Sanchez,et al.  Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients. , 1981, The Journal of clinical endocrinology and metabolism.

[42]  F. Luft,et al.  Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. , 1980, Journal of chronic diseases.

[43]  R. Gillum.  Pathophysiology of Hypertension in Blacks and Whites: A Review of the Basis of Racial Blood Pressure Differences , 1979, Hypertension.

[44]  R. Stone,et al.  Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. , 1977, The Journal of clinical investigation.

[45]  F. Luft,et al.  Differences in response to sodium administration in normotensive white and black subjects. , 1977, The Journal of laboratory and clinical medicine.

[46]  J. D'Elia,et al.  Plasma Renin Activity and Hypertension in Diabetes Mellitus , 1976, Diabetes.

[47]  C. Gomez-Sanchez,et al.  The intravenous furosemide test: a simple way to evaluate renin responsiveness. , 1976, Annals of internal medicine.

[48]  J. Laragh,et al.  Renin as a risk factor in essential hypertension: more evidence. , 1973, The American journal of medicine.

[49]  W. E. Judson,et al.  Metabolic Studies on Hypertensive Patients with Suppressed Plasma Renin Activity Not Due to Hyperaldosteronism , 1968, Circulation.